| Year |
Citation |
Score |
| 2023 |
Tiwari S, Kaur P, Gupta D, Chaudhury S, Chaudhary M, Mittal A, Kumar S, Sahu SK. An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets. Endocrine, Metabolic & Immune Disorders Drug Targets. PMID 37218182 DOI: 10.2174/1871530323666230522112758 |
0.376 |
|
| 2023 |
Bhimanwar RS, Lokhande KB, Shrivastava A, Singh A, Chitlange SS, Mittal A. Identification of potential drug candidates as TGR5 agonist to combat type II diabetes using docking and molecular dynamics simulation studies. Journal of Biomolecular Structure & Dynamics. 1-18. PMID 36724473 DOI: 10.1080/07391102.2023.2173654 |
0.308 |
|
| 2021 |
Tiwari S, Kaur P, Gupta D, Chaudhury S, Chaudhary M, Chandra A, Sahu SK, Mittal A, Kumar S. Withdrawal Notice: Therapeutic Targets Underlying the Evolution of Po-tential Anti-Diabetic Agents: A Comprehensive Review Current Diabetes Reviews. PMID 34872480 DOI: 10.2174/1573399818666211206100235 |
0.328 |
|
| 2021 |
Sharma S, Mittal A, Kumar S, Mittal A. Structural Perspectives and Advancement of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes. Current Diabetes Reviews. PMID 34538233 DOI: 10.2174/1573399817666210917122745 |
0.413 |
|
| 2021 |
Kumar S, Mittal A, Mittal A. A review upon medicinal perspective and designing rationale of DPP-4 inhibitors. Bioorganic & Medicinal Chemistry. 46: 116354. PMID 34428715 DOI: 10.1016/j.bmc.2021.116354 |
0.419 |
|
| 2020 |
Kumar S, Mittal A, Babu D, Mittal A. Herbal medicines for diabetes management and its secondary complications. Current Diabetes Reviews. PMID 33143632 DOI: 10.2174/1573399816666201103143225 |
0.401 |
|
| 2019 |
Kumar S, Khatik GL, Mittal A. Recent Developments in Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors as a Valuable Tool in the Treatment of Type 2 Diabetes Mellitus. Mini Reviews in Medicinal Chemistry. PMID 32134370 DOI: 10.2174/1389557519666191009163519 |
0.613 |
|
| 2018 |
Kumar S, Khatik GL, Mittal A. In-silico Molecular Docking Study to Search New SGLT2 Inhibitor based on Dioxabicyclo[3.2.1] octane Scaffold. Current Computer-Aided Drug Design. PMID 30345926 DOI: 10.2174/1573409914666181019165821 |
0.599 |
|
| 2018 |
Kaur P, Mittal A, Nayak SK, Vyas M, Mishra V, Khatik GL. Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus. Current Drug Targets. PMID 30051787 DOI: 10.2174/1389450119666180727142902 |
0.603 |
|
| 2017 |
Khatik GL, Datusalia AK, Ahsan W, Kaur P, Vyas M, Mittal A, Nayak SK. A Retrospect Study on Thiazole Derivatives as the Potential Antidiabetic Agents in Drug Discovery & Developments. Current Drug Discovery Technologies. PMID 28914188 DOI: 10.2174/1570163814666170915134018 |
0.536 |
|
| 2017 |
Mittal AK, Dubey M, Arora M, Bhagat S, Bhargava AK. Anaesthetic consideration for robotic nipple sparing mastectomy. Indian Journal of Anaesthesia. 61: 519-521. PMID 28655964 DOI: 10.4103/ija.IJA_130_17 |
0.431 |
|
| 2014 |
Komers R, Xu B, Fu Y, McClelland A, Kantharidis P, Mittal A, Cohen HT, Cohen DM. Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatment. Plos One. 9: e96987. PMID 24827579 DOI: 10.1371/journal.pone.0096987 |
0.323 |
|
| 2006 |
Ramachandran U, Kumar R, Mittal A. Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome Mini-Reviews in Medicinal Chemistry. 6: 563-573. PMID 16719831 DOI: 10.2174/138955706776876140 |
0.321 |
|
| Show low-probability matches. |